The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response

被引:1
|
作者
Rivas-Fuentes, Selma [1 ]
Salgado-Aguayo, Alfonso [2 ]
Santos-Mendoza, Teresa [1 ]
Sevilla-Reyes, Edgar [1 ]
机构
[1] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab Transcript & Mol Immunol, Mexico City 14080, Mexico
[2] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab Res Rheumat Dis, Mexico City 14080, Mexico
关键词
RSV; CX3CL1; CX3CR1; immune response; DENDRITIC CELLS; G-PROTEIN; CHEMOKINE FRACTALKINE; RECEPTOR CX3CR1; IN-VITRO; T-CELLS; B-CELLS; EXPRESSION; IDENTIFICATION; MONOCYTES;
D O I
10.3390/ijms25189800
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Respiratory syncytial virus (RSV) is a common respiratory pathogen that causes respiratory illnesses, ranging from mild symptoms to severe lower respiratory tract infections in infants and older adults. This virus is responsible for one-third of pneumonia deaths in the pediatric population; however, there are currently only a few effective vaccines. A better understanding of the RSV-host relationship at the molecular level may lead to a more effective management of RSV-related symptoms. The fractalkine (CX3CL1) receptor (CX3CR1) is a co-receptor for RSV expressed by airway epithelial cells and diverse immune cells. RSV G protein binds to the CX3CR1 receptor via a highly conserved amino acid motif (CX3C motif), which is also present in CX3CL1. The CX3CL1-CX3CR1 axis is involved in the activation and infiltration of immune cells into the infected lung. The presence of the RSV G protein alters the natural functions of the CX3CR1-CX3CL1 axis and modifies the host's immune response, an aspects that need to be considered in the development of an efficient vaccine and specific pharmacological treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] m6A Reader YTHDC1 Impairs Respiratory Syncytial Virus Infection by Downregulating Membrane CX3CR1 Expression
    Picavet, Lucas W.
    van Vroonhoven, Ellen C. N.
    Scholman, Rianne C.
    Smits, Yesper T. H.
    Banerjee, Rupa
    Besteman, Sjanna B.
    Viveen, Mattheus C.
    van der Vlist, Michiel M.
    Tanenbaum, Marvin E.
    Lebbink, Robert J.
    Vastert, Sebastiaan J.
    van Loosdregt, Jorg
    VIRUSES-BASEL, 2024, 16 (05):
  • [22] CX3CL1 and CX3CR1 could be a relevant molecular axis in the pathophysiology of idiopathic pulmonary fibrosis
    Rivas-Fuentes, Selma
    Herrera, Iliana
    Salgado-Aguayo, Alfonso
    Buendia-Roldan, Ivette
    Becerril, Carina
    Cisneros, Jose
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (15): : 2357 - 2361
  • [23] The role of the CX3CL1/CX3CR1 axis as potential inflammatory biomarkers in subjects with periodontitis and rheumatoid arthritis: A systematic review
    Alarcon-Sanchez, Mario A.
    Becerra-Ruiz, Julieta S.
    Guerrero-Velazquez, Celia
    Mosaddad, Seyed A.
    Heboyan, Artak
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (02)
  • [24] Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction
    Roy-Chowdhury, Eva
    Brauns, Nicolas
    Helmke, Alexandra
    Nordlohne, Johannes
    Braesen, Jan Hinrich
    Schmitz, Jessica
    Volkmann, Julia
    Fleig, Susanne, V
    Kusche-Vihrog, Kristina
    Haller, Hermann
    von Vietinghoff, Sibylle
    CARDIOVASCULAR RESEARCH, 2021, 117 (06) : 1510 - 1522
  • [25] The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
    Wojdasiewicz, Piotr
    Poniatowski, Lukasz A.
    Kotela, Andrzej
    Deszczynski, Jaroslaw
    Kotela, Ireneusz
    Szukiewicz, Dariusz
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (05) : 395 - 403
  • [26] Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments
    Wada, Akinori
    Ito, Aya
    Iitsuka, Hirofumi
    Tsuneyama, Koichi
    Miyazono, Takayoshi
    Murakami, Jun
    Shibahara, Naotoshi
    Sakurai, Hiroaki
    Saiki, Ikuo
    Nakayama, Takashi
    Yoshie, Osamu
    Koizumi, Keiichi
    Sugiyama, Toshiro
    ONCOLOGY REPORTS, 2015, 33 (06) : 2935 - 2939
  • [27] Correlation of CX3CL1 and CX3CR1 Levels with Response to Infliximab Therapy in Patients with Rheumatoid Arthritis
    Odai, Tsuyoshi
    Matsunawa, Mizuho
    Takahashi, Ryo
    Wakabayashi, Kuninobu
    Isozaki, Takeo
    Yajima, Nobuyuki
    Miwa, Yusuke
    Kasama, Tsuyoshi
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) : 1158 - 1165
  • [28] Diet-Induced Obesity Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma via CX3CL1/CX3CR1 Axis
    Sun, Yue
    Zhang, Xiao-Xin
    Huang, Shan
    Pan, Hong
    Gai, Yan-Zhi
    Zhou, Yao-Qi
    Zhu, Lei
    Nie, Hui-Zhen
    Li, Dong-Xue
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [29] Role of CX3CL1 in Diseases
    Liu, WangMi
    Jiang, Libo
    Bian, Chong
    Liang, Yun
    Xing, Rong
    Yishakea, Mumingjiang
    Dong, Jian
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 (05) : 371 - 383
  • [30] Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review
    Rivas-Fuentes, Selma
    Salgado-Aguayo, Alfonso
    Arratia-Quijada, Jenny
    Gorocica-Rosete, Patricia
    JOURNAL OF CANCER, 2021, 12 (02): : 571 - 583